These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30844797)

  • 21. Molecular bases for multidrug resistance in Yersinia pseudotuberculosis.
    Cabanel N; Galimand M; Bouchier C; Chesnokova M; Klimov V; Carniel E
    Int J Med Microbiol; 2017 Oct; 307(7):371-381. PubMed ID: 28830739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Activity of antibacterial preparations against the causative agent of pseudotuberculosis in vitro].
    Vasil'ev PG; Kalininskiĭ VB; Vasil'ev NT; Iurchenko AV
    Antibiot Khimioter; 1990 Jun; 35(6):29-31. PubMed ID: 2400288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of recombinant porin from Y. pseudotuberculosis in a water-soluble form for pseudotuberculosis diagnostics.
    Golotin V; Portnyagina O; Chopenko N; Kim N; Rasskazov V; Novikova O
    Biol Chem; 2017 Oct; 398(11):1229-1236. PubMed ID: 28723607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An NF-κB-based high-throughput screen identifies piericidins as inhibitors of the Yersinia pseudotuberculosis type III secretion system.
    Duncan MC; Wong WR; Dupzyk AJ; Bray WM; Linington RG; Auerbuch V
    Antimicrob Agents Chemother; 2014; 58(2):1118-26. PubMed ID: 24295981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homology models of the Yersinia pseudotuberculosis and Yersinia pestis general porins and comparative analysis of their functional and antigenic regions.
    Likhatskaya GN; Solov'eva TF; Novikova OD; Issaeva MP; Gusev KV; Kryzhko IB; Trifonov EV; Nurminski EA
    J Biomol Struct Dyn; 2005 Oct; 23(2):163-74. PubMed ID: 16060690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of porin from the outer membrane of Yersinia pseudotuberculosis for serodiagnosis of pseudotuberculosis].
    Novikova OD; Portniagina OIu; Frolova GM; Solov'eva TF; Pavlova TN; Timchenko NF; Prokopenkova AP; Ovodov IuS
    Biull Eksp Biol Med; 1995 Aug; 120(8):199-202. PubMed ID: 7579285
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunogenicity and Protective Activity of a Chimeric Protein Based on the Domain III of the Tick-Borne Encephalitis Virus E Protein and the OmpF Porin of
    Sanina N; Chopenko N; Mazeika A; Davydova L; Leonova G; Stenkova A; Uversky VN; Kostetsky E
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The protective properties of a porin from the outer membrane of Yersinia pseudotuberculosis].
    Timchenko NF; Novikova OD; Pavlova TN; Venediktov VS; Solov'eva TF
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Nov; (11):48-50. PubMed ID: 1965874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inclusion Bodies of Recombinant OmpF Porin from Yersinia pseudotuberculosis: Properties and Structural Characterization.
    Khomenko VA; Sidorin EV; Bakholdina SI; Naberezhnykh GA; Kim NY; Stenkova AM; Chernysheva NY; Isaeva MP; Solov'eva TF
    Biochemistry (Mosc); 2019 Jun; 84(6):672-685. PubMed ID: 31238867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toward screening for antibiotics with enhanced permeation properties through bacterial porins.
    Hajjar E; Bessonov A; Molitor A; Kumar A; Mahendran KR; Winterhalter M; Pagès JM; Ruggerone P; Ceccarelli M
    Biochemistry; 2010 Aug; 49(32):6928-35. PubMed ID: 20604536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of ompC and ompF in multidrug-resistant Shigella dysenteriae and Shigella flexneri by aqueous extract of Aegle marmelos, altering its susceptibility toward beta-lactam antibiotics.
    Raja SB; Murali MR; Devaraj SN
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):321-8. PubMed ID: 18358664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antimicrobial susceptibility of Yersinia enterocolitica and Yersinia pseudotuberculosis strains isolated from humans in Poland during 2004-2009].
    Szych J; Jakubczak A; Wardak S; Madajczak G
    Med Dosw Mikrobiol; 2009; 61(4):311-9. PubMed ID: 20201320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subpopulations of Stressed Yersinia pseudotuberculosis Preferentially Survive Doxycycline Treatment within Host Tissues.
    Raneses JR; Ellison AL; Liu B; Davis KM
    mBio; 2020 Aug; 11(4):. PubMed ID: 32753491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Influence of glucose and galactose on the morphology and biological properties of Yersinia pseudotuberculosis].
    Bakholdina SI; Solov'eva TF; Shubin FN; Timchenko NF
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (5):6-10. PubMed ID: 16279525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characteristics of OmpF-like porins from pathogenic Yersinia.
    Guzev KV; Isaeva MP; Novikova OD; Solov'eva TF; Rasskazov VA
    Biochemistry (Mosc); 2005 Oct; 70(10):1104-10. PubMed ID: 16271025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An antibiotic-resistance conferring mutation in a neisserial porin: Structure, ion flux, and ampicillin binding.
    Bartsch A; Ives CM; Kattner C; Pein F; Diehn M; Tanabe M; Munk A; Zachariae U; Steinem C; Llabrés S
    Biochim Biophys Acta Biomembr; 2021 Jun; 1863(6):183601. PubMed ID: 33675718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic antibacterial effect of apigenin with β-lactam antibiotics and modulation of bacterial resistance by a possible membrane effect against methicillin resistant Staphylococcus aureus.
    Akilandeswari K; Ruckmani K
    Cell Mol Biol (Noisy-le-grand); 2016 Dec; 62(14):74-82. PubMed ID: 28145860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Yersinia pseudotuberculosis mutant OmpF porins with deletions of the external loops: genetic constructions design, expression, isolation and refolding].
    Sidorova OV; Isaeva MP; Khomenko VA; Portniagina OIu; Likhatskaia GN; Kim NIu; Novikova OD; Chistiulin DK; Solov'eva TF
    Bioorg Khim; 2012; 38(2):156-65. PubMed ID: 22792719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-Organization of Recombinant Membrane Porin OmpF from Yersinia pseudotuberculosis in Aqueous Environments.
    Sidorin EV; Khomenko VA; Kim NY; Dmitrenok PS; Stenkova AM; Novikova OD; Solov'eva TF
    Biochemistry (Mosc); 2017 Nov; 82(11):1304-1313. PubMed ID: 29223157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In silico and in vitro analysis of cross-reactivity between Yersinia pseudotuberculosis OmpF porin and thyroid-stimulating hormone receptor.
    Portnyagina O; Zelepuga E; Khomenko V; Solov'eva E; Solov'eva T; Novikova O
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2484-2491. PubMed ID: 29079441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.